Market Cap 151.86M
Revenue (ttm) 118.71M
Net Income (ttm) -30.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 783.33
Profit Margin -25.59%
Debt to Equity Ratio 0.52
Volume 274,300
Avg Vol 374,140
Day's Range N/A - N/A
Shares Out 6.46M
Stochastic %K 100%
Beta 0.51
Analysts Hold
Price Target $24.43

Company Profile

Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut sy...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 224 419 7106
Fax: 510 744 8001
Address:
100 South Saunders Road, Suite 300, Lake Forest, United States
Bobear12
Bobear12 Jul. 26 at 11:26 PM
$ASRT anyone own GALT?
0 · Reply
Swordfisher
Swordfisher Jul. 24 at 9:13 PM
$ASRT ASRT…..RIP🪦
0 · Reply
11thestate
11thestate Jul. 24 at 3:18 PM
Shareholders who bought $SPPI $ASRT in 2022 have until October 12, 2026 to file a claim in the $7M Spectrum Pharmaceuticals settlement. The settlement claims that Spectrum misled investors about poziotinib's dosing strategy, its communications with the FDA, and the status of its confirmatory PINNACLE study. Eligible investors can still submit a claim before the deadline: https://11th.com/cases/sppi-investor-settlement
0 · Reply
11thestate
11thestate Jul. 20 at 5:08 PM
Everything You Need to Know About the $15.95M $SPPI / $ASRT Settlement Payout: Q: What happened? A: Spectrum Pharmaceuticals ($SPPI) agreed to a $15.95 million settlement over claims that it misled investors about the effectiveness and FDA approval prospects of its lead drug candidates, Poziotinib and Rolontis. Investors alleged the company concealed poor clinical results, manufacturing issues, and regulatory risks while continuing to present the drugs as being close to approval. Q: Am I actually eligible? A: If you bought $SPPI shares between 2018 and 2021, you’re likely eligible. You don’t need to still hold the stock to claim; past losses count Q: When do payouts happen? A: Typically, within 4–9 months after the claim deadline. But the exact timing depends on the court and settlement administration. Q: I missed the deadline. Is it too late? A: You may still be able to file a late claim but acceptance depends on final approval by the court. Check if you eligible and file your claim: https://11th.com/cases/spectrum-investor-settlement
0 · Reply
Invest2live
Invest2live Jul. 17 at 1:24 PM
$ASRT 128% already; congrats 🌿🎉🌷 Checkout $AKBA and $RXRX; undervalued and great growth potential.
0 · Reply
11thestate
11thestate Jul. 15 at 12:41 PM
The $7M Spectrum Pharmaceuticals investor settlement is now accepting claims. Investors who purchased $SPPI /$ASRT shares in 2022 may still be eligible to participate: https://11th.com/cases/sppi-investor-settlement
0 · Reply
11thestate
11thestate Jul. 9 at 1:47 PM
$SPPI / $ASRT Settlement Update: The court has approved the $7M investor settlement. The case alleged that Spectrum Pharmaceuticals misled the market about poziotinib’s dosing, FDA interactions, and the status of its PINNACLE confirmatory study. In September 2022, FDA briefing materials and an advisory committee meeting raised concerns about the drug’s safety, effectiveness, and approval path, causing $SPPI to fall sharply. With the settlement now approved, eligible investors may be able to submit a claim: https://11th.com/cases/sppi-investor-settlement
0 · Reply
11thestate
11thestate Jul. 6 at 2:42 PM
$SPPI / $ASRT lost more than 88% after clinical trial failures and FDA setbacks, and the company later agreed to a $15.95M investor settlement. If you bought or held $SPPI between 2018 and 2021, you may still be able to recover losses from, as late claims are currently being accepted: https://11th.com/cases/spectrum-investor-settlement
0 · Reply
Swordfisher
Swordfisher Jul. 3 at 5:24 PM
$ASRT Did everyone ultimately get what funds they had left coming to them at this point. I’m assuming so as just popped in To see if or what may still be going on, but no posts or such for a while now. Well here’s to lessons learned and brighter & more prosperous prospects going forward!!💵🥃
1 · Reply
Swordfisher
Swordfisher Jun. 23 at 11:38 PM
$ASRT A sad ending to what was once a strong company (DEPOMED).💁🏻‍♂️👎🙁
1 · Reply
Latest News on ASRT
Assertio Holdings Quarterly report: Q1 2026

May 8, 2026, 7:00 AM EDT - 2 months ago

Assertio Holdings Quarterly report: Q1 2026


Assertio Provides Update on Garda Therapeutics Tender Process

Apr 21, 2026, 5:00 PM EDT - 3 months ago

Assertio Provides Update on Garda Therapeutics Tender Process


Assertio Holdings Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Assertio Holdings Proxy statement: Proxy filing


Assertio Holdings Earnings Call Transcript: Q4 2025

Mar 16, 2026, 4:30 PM EDT - 4 months ago

Assertio Holdings Earnings Call Transcript: Q4 2025


Assertio Holdings Annual report: Q4 2025

Mar 16, 2026, 4:30 PM EDT - 4 months ago

Assertio Holdings Annual report: Q4 2025


Assertio Holdings Earnings release: Q4 2025

Mar 16, 2026, 4:30 PM EDT - 4 months ago

Assertio Holdings Earnings release: Q4 2025


Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split

Dec 22, 2025, 4:30 PM EST - 7 months ago

Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split


Assertio Holdings Earnings Call Transcript: Q3 2025

Nov 10, 2025, 4:30 PM EST - 9 months ago

Assertio Holdings Earnings Call Transcript: Q3 2025


Assertio Holdings Quarterly report: Q3 2025

Nov 10, 2025, 4:30 PM EST - 9 months ago

Assertio Holdings Quarterly report: Q3 2025


Assertio Holdings Earnings release: Q3 2025

Nov 10, 2025, 4:30 PM EST - 9 months ago

Assertio Holdings Earnings release: Q3 2025


Assertio Reports Third Quarter 2025 Financial Results

Nov 10, 2025, 4:13 PM EST - 9 months ago

Assertio Reports Third Quarter 2025 Financial Results


Assertio Announces Leadership Transition

Oct 28, 2025, 9:15 AM EDT - 9 months ago

Assertio Announces Leadership Transition


Assertio Holdings Earnings Call Transcript: Q2 2025

Aug 11, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Earnings Call Transcript: Q2 2025


Assertio Holdings Quarterly report: Q2 2025

Aug 11, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Quarterly report: Q2 2025


Assertio Holdings Earnings release: Q2 2025

Aug 11, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Earnings release: Q2 2025


Assertio Reports Second Quarter 2025 Financial Results

Aug 11, 2025, 4:05 PM EDT - 1 year ago

Assertio Reports Second Quarter 2025 Financial Results


Assertio Holdings Slides: Corporate Presentation

May 21, 2025, 7:00 AM EDT - 1 year ago

Assertio Holdings Slides: Corporate Presentation


Assertio Holdings Earnings Call Transcript: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Earnings Call Transcript: Q1 2025


Assertio Holdings Quarterly report: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Quarterly report: Q1 2025


Assertio Holdings Earnings release: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Earnings release: Q1 2025


Assertio Reports First Quarter 2025 Financial Results

May 12, 2025, 4:01 PM EDT - 1 year ago

Assertio Reports First Quarter 2025 Financial Results


Assertio Holdings Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Assertio Holdings Proxy statement: Proxy Filing


Assertio Holdings Proxy statement: Proxy Filing

Mar 25, 2025, 8:00 AM EDT - 1 year ago

Assertio Holdings Proxy statement: Proxy Filing


Assertio Holdings Earnings Call Transcript: Q4 2024

Mar 12, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Earnings Call Transcript: Q4 2024


Assertio Holdings Annual report: Q4 2024

Mar 12, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Annual report: Q4 2024


Assertio Holdings Earnings release: Q4 2024

Mar 12, 2025, 4:30 PM EDT - 1 year ago

Assertio Holdings Earnings release: Q4 2024


Assertio Holdings Earnings Call Transcript: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Assertio Holdings Earnings Call Transcript: Q3 2024


Assertio Holdings Quarterly report: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Assertio Holdings Quarterly report: Q3 2024


Assertio Holdings Earnings release: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Assertio Holdings Earnings release: Q3 2024


Assertio Reports Third Quarter 2024 Financial Results

Nov 11, 2024, 4:02 PM EST - 1 year ago

Assertio Reports Third Quarter 2024 Financial Results


Assertio Provides Response to Letter from Short-seller

Nov 11, 2024, 7:30 AM EST - 1 year ago

Assertio Provides Response to Letter from Short-seller


Assertio Holdings Earnings Call Transcript: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

Assertio Holdings Earnings Call Transcript: Q2 2024


Assertio Holdings Quarterly report: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

Assertio Holdings Quarterly report: Q2 2024


Assertio Reports Second Quarter 2024 Financial Results

Aug 7, 2024, 4:01 PM EDT - 2 years ago

Assertio Reports Second Quarter 2024 Financial Results


Bobear12
Bobear12 Jul. 26 at 11:26 PM
$ASRT anyone own GALT?
0 · Reply
Swordfisher
Swordfisher Jul. 24 at 9:13 PM
$ASRT ASRT…..RIP🪦
0 · Reply
11thestate
11thestate Jul. 24 at 3:18 PM
Shareholders who bought $SPPI $ASRT in 2022 have until October 12, 2026 to file a claim in the $7M Spectrum Pharmaceuticals settlement. The settlement claims that Spectrum misled investors about poziotinib's dosing strategy, its communications with the FDA, and the status of its confirmatory PINNACLE study. Eligible investors can still submit a claim before the deadline: https://11th.com/cases/sppi-investor-settlement
0 · Reply
11thestate
11thestate Jul. 20 at 5:08 PM
Everything You Need to Know About the $15.95M $SPPI / $ASRT Settlement Payout: Q: What happened? A: Spectrum Pharmaceuticals ($SPPI) agreed to a $15.95 million settlement over claims that it misled investors about the effectiveness and FDA approval prospects of its lead drug candidates, Poziotinib and Rolontis. Investors alleged the company concealed poor clinical results, manufacturing issues, and regulatory risks while continuing to present the drugs as being close to approval. Q: Am I actually eligible? A: If you bought $SPPI shares between 2018 and 2021, you’re likely eligible. You don’t need to still hold the stock to claim; past losses count Q: When do payouts happen? A: Typically, within 4–9 months after the claim deadline. But the exact timing depends on the court and settlement administration. Q: I missed the deadline. Is it too late? A: You may still be able to file a late claim but acceptance depends on final approval by the court. Check if you eligible and file your claim: https://11th.com/cases/spectrum-investor-settlement
0 · Reply
Invest2live
Invest2live Jul. 17 at 1:24 PM
$ASRT 128% already; congrats 🌿🎉🌷 Checkout $AKBA and $RXRX; undervalued and great growth potential.
0 · Reply
11thestate
11thestate Jul. 15 at 12:41 PM
The $7M Spectrum Pharmaceuticals investor settlement is now accepting claims. Investors who purchased $SPPI /$ASRT shares in 2022 may still be eligible to participate: https://11th.com/cases/sppi-investor-settlement
0 · Reply
11thestate
11thestate Jul. 9 at 1:47 PM
$SPPI / $ASRT Settlement Update: The court has approved the $7M investor settlement. The case alleged that Spectrum Pharmaceuticals misled the market about poziotinib’s dosing, FDA interactions, and the status of its PINNACLE confirmatory study. In September 2022, FDA briefing materials and an advisory committee meeting raised concerns about the drug’s safety, effectiveness, and approval path, causing $SPPI to fall sharply. With the settlement now approved, eligible investors may be able to submit a claim: https://11th.com/cases/sppi-investor-settlement
0 · Reply
11thestate
11thestate Jul. 6 at 2:42 PM
$SPPI / $ASRT lost more than 88% after clinical trial failures and FDA setbacks, and the company later agreed to a $15.95M investor settlement. If you bought or held $SPPI between 2018 and 2021, you may still be able to recover losses from, as late claims are currently being accepted: https://11th.com/cases/spectrum-investor-settlement
0 · Reply
Swordfisher
Swordfisher Jul. 3 at 5:24 PM
$ASRT Did everyone ultimately get what funds they had left coming to them at this point. I’m assuming so as just popped in To see if or what may still be going on, but no posts or such for a while now. Well here’s to lessons learned and brighter & more prosperous prospects going forward!!💵🥃
1 · Reply
Swordfisher
Swordfisher Jun. 23 at 11:38 PM
$ASRT A sad ending to what was once a strong company (DEPOMED).💁🏻‍♂️👎🙁
1 · Reply
Chuckuk
Chuckuk Jun. 22 at 9:57 AM
$ASRT money is in today
1 · Reply
Chuckuk
Chuckuk Jun. 21 at 8:37 AM
$ASRT Just 3M non temderers means compo will be better for us
2 · Reply
Passamaquoddy
Passamaquoddy Jun. 18 at 1:09 PM
$ASRT Haha apparently b/c they closed the deal before the expiry date on my $20 June covered calls I get the $23.50 BO price. Pleasant surprise.
0 · Reply
PeterDeboner
PeterDeboner Jun. 18 at 1:32 AM
$ASRT pos f u been here since sppi. F isn't real.
1 · Reply
BigBadBeethoven
BigBadBeethoven Jun. 17 at 9:01 PM
$ASRT I didn't tender my shares. I could not in good conscience agree to this deal . They even had a much better offer they didn't take. It must be that all the perks under the table were much better in this deal
1 · Reply
Chuckuk
Chuckuk Jun. 17 at 7:52 AM
$ASRT Bit shocking to see no value on the broker account for ASRT
1 · Reply
haddykatz
haddykatz Jun. 16 at 10:11 PM
$ASRT how long does it normally take to get paid for shares I didn’t tender, from what I understand it’s normally 1-3 days…
1 · Reply
focafoca99
focafoca99 Jun. 16 at 9:22 PM
$ASRT completed its merger with Zydus Worldwide DMCC, becoming a wholly owned subsidiary of the parent.
0 · Reply
Swordfisher
Swordfisher Jun. 16 at 9:10 PM
1 · Reply
Swordfisher
Swordfisher Jun. 16 at 9:08 PM
0 · Reply
TwongStocks
TwongStocks Jun. 16 at 8:40 PM
$ASRT Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027 https://www.businesswire.com/news/home/20260616901266/en/Assertio-Announces-Completion-of-Merger-with-Zydus-Lifesciences-and-Fundamental-Change-and-Make-Whole-Fundamental-Change-Relating-to-its-Outstanding-6.50-Convertible-Senior-Notes-due-2027 Effective today, Assertio common stock has been delisted from the Nasdaq Stock Exchange. Assertio stockholders are receiving $23.50 per share in cash in connection with the acquisition.
0 · Reply
Chuckuk
Chuckuk Jun. 16 at 2:31 PM
$ASRT I have lumped in with Monteverdelaw send an email to Juan Monteverde and ask to be included will not commnet on the action as he has a client he is working with but we shoudl be included in the class action. Keep your trading records and I sent hom ownership proof of my 14633. We will see he is a great person with a good record if he feels it is worth pursuing.
2 · Reply